Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

Accueil
Investir
ETFs
Etats-Unis
AMEX
Ishares Diversified Alternatives Trust (ALT)
Ishares Diversified Alternatives Trust (ALT) Actualités

Ishares Diversified Alternatives Trust (ALT)

0,00

0,00

( 0,00% )

Mis à jour : -

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

PharmAthene Reports Year-End 2016 Financial and Operational Results

PharmAthene Reports Year-End 2016 Financial and Operational Results PR Newswire ANNAPOLIS, Md., March 14, 2017 ANNAPOLIS, Md., March 14, 2017...

Altran North America and MISTRAS Group Enter Into Multi-Year Teaming Agreement

PRINCETON JUNCTION, N.J., July 18, 2014 (GLOBE NEWSWIRE) -- MISTRAS Group, Inc. (NYSE:MG), is pleased to...

Altran Group Analyst & Investor Day

Interview with Chairman & Chief Executive Philippe Salle Altran (Paris:ALT), the global leader in innovation and high-tech engineering...

(25-NSE)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Quarterly Report (10-q)

Table of Contents UNITED STATES SECURITIES AND...

Alteon Reverse Stock Split and Name Change to Become Effective on July 25th

MONTVALE, N.J., July 24 /PRNewswire-FirstCall/ -- Alteon Inc. (AMEX:ALT) announces that the reverse stock split of its common stock and name...

Alteon Stockholders Approve Amendments to Certificate of Incorporation at Annual Meeting

** Name Change to Synvista Therapeutics, Inc. and Reverse Stock Split to be Effective July 25 ** MONTVALE, N.J., July 20 /PRNewswire-FirstCall/...

Alteon to Hold Annual Meeting of Stockholders

COMPANY PRESENTATION TO BE WEBCAST LIVE MONTVALE, N.J., July 18 /PRNewswire-FirstCall/ -- Alteon Inc. (AMEX:ALT) announces that its Annual...

Alteon Appoints Jacob Victor, Ph.D. to Lead Development of Haptoglobin Diagnostic Test

MONTVALE, N.J., July 16 /PRNewswire-FirstCall/ -- Alteon Inc. (AMEX:ALT) announces the appointment of Jacob Victor, Ph.D. as Executive Director...

Alteon Initiates Phase 2 Trial of ALT-2074 in Diabetes and Haptoglobin 2-2

Proof of Concept Study for Pharmacogenomic Indication MONTVALE, N.J., June 28 /PRNewswire-FirstCall/ -- Alteon Inc. (AMEX:ALT) announced today...

Alteon to Present at Rodman & Renshaw's Annual Health Care Conference

MONTVALE, N.J., May 11 /PRNewswire-FirstCall/ -- Alteon Inc. (AMEX:ALT) announced today that Noah Berkwitz, MD, PhD, President and Chief...

Alteon Issues Update Regarding Auditors' Going Concern Report

MONTVALE, N.J., April 19 /PRNewswire-FirstCall/ -- Alteon Inc. (AMEX:ALT) In compliance with the AMEX Company Guide Rule 610(b) requiring a...

OXIS International Expands Licensing Deal with Alteon to Include Exclusive Rights of Organoselenium Compounds for All Indication

OXIS International, Inc. (OTCBB: OXIS) announced today that Alteon, Inc. (AMEX: ALT) has entered into a worldwide exclusive...

Alteon Announces Entry Into Definitive Documents for the Sale of $25 Million in a Private Financing of Its Series B Preferred St

MONTVALE, N.J., April 9 /PRNewswire-FirstCall/ -- Alteon Inc. (AMEX:ALT) announced today that it has entered into a definitive agreement with...

Forums

Afficher les forums

Hat Trick Beverage (EM)

L&G Emerging Markets Equ...

Ci Global Smallmid Cap E...

Montello Resources (EM)

Universal New Energy (ID)

Bmo Global Equity Fund S...

iShares US Home Construc...

Direxion Daily S&P 500 B...

Technip Energies NV

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

ADVFN

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.